| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 07/06/1994 | EP0604848A2 Quick-drying gel-type disinfectant for hands and fingers |
| 07/06/1994 | EP0604744A2 Method for treating systemic inflammatory response syndrome |
| 07/06/1994 | EP0604603A1 Cadherin materials and methods |
| 07/05/1994 | US5326788 Inactivating viruses with aromatic polycyclic diones |
| 07/05/1994 | US5326761 Suspension; sustained release |
| 07/05/1994 | US5326569 Medical foods for the nutritional support of child/adult metabolic diseases |
| 07/05/1994 | US5326568 Implanting insert having drug-containing, biodegradable concentric shells |
| 06/30/1994 | CA2605872A1 Intermediates for retroviral protease inhibiting compounds |
| 06/29/1994 | EP0603312A1 Novel gaba a? receptor with steroid binding sites |
| 06/29/1994 | EP0603301A1 Pharmaceutical preparation containing an uricosuric and an excitatory amino acid antagonist |
| 06/29/1994 | EP0470183B1 Fibroblast growth factor conjugates |
| 06/28/1994 | US5324775 Bound to a synthetic non-immunogenic hydrophilic polyethylene glycol polymer; can be injected into humans to augment soft tissue |
| 06/28/1994 | US5324748 Method for enhancement of 1-series PG production |
| 06/28/1994 | US5324731 Method of inhibiting transformation of cells in which purine metabolic enzyme activity is elevated |
| 06/28/1994 | US5324519 Biodegradable polymer composition |
| 06/28/1994 | CA1330422C Reduction of neurotoxic effects of cytotoxic agents |
| 06/23/1994 | WO1994013791A1 Regulatable nucleic acid therapeutic and methods of use thereof |
| 06/23/1994 | WO1994013687A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis |
| 06/23/1994 | WO1994013635A1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
| 06/23/1994 | WO1994013319A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | WO1994013305A1 Method of ophthalmic drug delivery |
| 06/23/1994 | WO1994013277A2 Use of dinaphthalenes compounds as antiproliferative agents |
| 06/23/1994 | WO1994013275A1 Glaucoma treatment |
| 06/23/1994 | WO1994013265A1 A free radical quenching liposomal composition |
| 06/23/1994 | WO1994008551A3 Pharmaceutical compositions and methods for treating cold symptoms |
| 06/23/1994 | CA2151927A1 Cathepsin d is an amyloidogenic protease in alzheimer's disease |
| 06/23/1994 | CA2151495A1 A free radical quenching liposomal composition |
| 06/23/1994 | CA2151235A1 5-methanesulfonamido-1-indanones as an inhibitor of cyclooxygenase-2 |
| 06/22/1994 | EP0603160A2 Compositions for in-situ active compound assembly |
| 06/22/1994 | EP0602686A2 Lectin concentrates of mistletoe extracts and corresponding standardized, stabilized mistletoe lectin preparations, process for their production as well as medicines containing them and their use |
| 06/21/1994 | US5322689 Copolymer of acrylic acid and fatty alcohol acrylate ester crosslinked with polyalkenyl polyether of polyhydric alcohol, volatile aromatic compound |
| 06/21/1994 | US5322688 Method of preparation of an extract from Ginkgo biloba leaves and pharmaceuticals containing the extract |
| 06/21/1994 | US5322678 Alteration of pharmacokinetics of proteins by charge modification |
| 06/21/1994 | CA1330344C Tetrahydrocarbazole esters |
| 06/21/1994 | CA1330306C Medicament for the treatment and prevention of nausea and vomiting |
| 06/21/1994 | CA1330295C Treatments employing vasoconstrictive substances in combination with cytotoxic agents for introduction into cellular lesion areas |
| 06/15/1994 | EP0601859A2 Pharmaceutic composition comprising cancer-related antibodies |
| 06/15/1994 | EP0601164A1 Methods for treating viral infections |
| 06/15/1994 | EP0600970A1 Use of interleukin-10 analogs or antagonists to treat endotoxin- or superantigen induced toxicity |
| 06/14/1994 | US5321017 Composition comprising fluriprofen and effectively non-antibacterial tetracycline to reduce bone loss |
| 06/14/1994 | US5321012 Using nontoxic material such as dextromethorphan, trifluoro-perazine, dextrorphan |
| 06/14/1994 | US5320852 Antacid microtablets |
| 06/09/1994 | WO1994012639A2 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | WO1994012638A2 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | WO1994012185A1 Combination of a calcium channel blocker and an antioxydant for treating ischemic diseases |
| 06/09/1994 | WO1994012162A1 Syndecan stimulation of cellular differentiation |
| 06/09/1994 | DE4312071A1 Dietetic prods. against smoking-related diseases - comprising confectionery prods. contg. beta-carotene |
| 06/09/1994 | CA2150117A1 Interleukin-3 (il-3) mutant polypeptides |
| 06/09/1994 | CA2150116A1 Interleukin-3 (il-3) multiple mutation polypeptides |
| 06/09/1994 | CA2147472A1 Treatment of ischemic diseases using a calcium channel blocker and an antioxidant |
| 06/08/1994 | EP0600591A2 Inhibition of tumor cell growth by administration of B7-transfected cells |
| 06/08/1994 | EP0600028A1 Use of selective ligands for treatment of disease states responsive to steroid or steroid-like hormones |
| 06/08/1994 | EP0599943A1 Leukotriene receptor antagonist-antihistamine complex |
| 06/08/1994 | EP0506853B1 The use of gaba-b selective agonists as anti-tussive agents |
| 06/08/1994 | CN1087643A Contraception method using competitive progesterone antagonists and novel compounds useful therein |
| 06/07/1994 | CA1330145C Protein label and drug delivery system |
| 06/07/1994 | CA1330039C Compounds having anti-progestational and anti-estrogenic activities for the treatment of hormone-dependent tumors |
| 06/07/1994 | CA1330036C Inhibition of arterial thrombotic occlusion or thromboembolism |
| 06/07/1994 | CA1330035C Pharmaceutical combination preparations for use in anti-neoplastic therapy |
| 06/01/1994 | EP0599819A2 Additives enhancing topical actions of therapeutic agents |
| 06/01/1994 | EP0514544B1 Immune complexes |
| 06/01/1994 | EP0484437A4 Renal-selective prodrugs for the treatment of hypertension |
| 05/31/1994 | US5316766 Thrombosis treatment with fibrinolytics and prostacyclins |
| 05/31/1994 | CA2110147A1 Method for treating systemic inflammatory response syndrome |
| 05/31/1994 | CA1329932C Acyl deoxyribonucleoside derivatives and uses thereof |
| 05/26/1994 | WO1994011535A1 Use of methioninase as an antitumor agent in anti-methionine chemotherapy |
| 05/26/1994 | WO1994011506A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | WO1994011385A1 17-alpha-acyl steroids which inhibit 5-alpha-reductase |
| 05/26/1994 | WO1994011338A1 Use of n-arylmethylene, ethylenediaminetriacetates n-arylmethylene iminodiacentates or n, n'-diarylmethylene ethylenediaminacetates for use in combatting oxidative stress |
| 05/26/1994 | WO1994011045A1 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
| 05/26/1994 | WO1994011027A1 Peripheralization of hematopoietic stem cells |
| 05/26/1994 | WO1994011026A2 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | WO1994011023A1 Monoclonal antibody which specifically binds to tumor vascular endothelium and uses thereof |
| 05/26/1994 | WO1994011012A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/26/1994 | WO1994011007A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | WO1994010995A1 Antitumour compositions containing taxane derivatives |
| 05/26/1994 | WO1994010989A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia |
| 05/26/1994 | WO1994010861A1 Method for enhancing bioavailability of beta-carotene |
| 05/26/1994 | WO1994006909A3 A method of preventing tumor metastasis |
| 05/26/1994 | WO1994004120A3 Methods of treating sexual dysfunction in animals with and h agonist |
| 05/26/1994 | CA2626445A1 Therapeutic application of chimeric and radiolabeled antibodies to human b lymphocyte restricted differentiation antigen for treatment of b cell lymphoma |
| 05/26/1994 | CA2149771A1 Adenovirus-mediated gene transfer to cardiac and vascular smooth muscle |
| 05/26/1994 | CA2149515A1 Methods and pharmaceutical compositions for enhanced cardiopulmonary resuscitation |
| 05/26/1994 | CA2149431A1 Use of n-arylmethylene ethylenediamine-triacetates, n-arylmethylene iminodiacetates or n,n'-diarylmethylene ethylenediaminacetates against oxidizing stress |
| 05/26/1994 | CA2149046A1 Purified ceramide-activated protein kinase, assay for identifying agents which act on same, and methods of using said agents |
| 05/26/1994 | CA2147503A1 Substituted dipeptide analogs promote release of growth hormone |
| 05/25/1994 | EP0597831A1 Arginine antagonists for inhibition of systemic hypotension associated with nitric oxide production or endothelial derived relaxing factor |
| 05/25/1994 | EP0597829A1 Novel monoclonal antibody to novel antigen associated with human tumors |
| 05/25/1994 | EP0357793B1 Suspended-release preparation prepared by using alginates |
| 05/25/1994 | EP0249629B1 Methods and materials for alleviation of pain symptoms of malignant neoplasia |
| 05/24/1994 | US5314685 Skin disorders |
| 05/19/1994 | CA2103294A1 Topical pharmaceutical composition for respiratory allergies |
| 05/18/1994 | EP0596912A1 Modulation and diagnosis of cytokine dysfunctions |
| 05/17/1994 | US5312818 (Interphenylene)7-oxabicycloheptane substituted (di)amide prostaglandin analog |
| 05/17/1994 | US5312817 Treatment of fatigue syndrome |
| 05/17/1994 | US5312816 Method of combatting osteoporosis in mammalian subjects, utilizing organic boron compounds |
| 05/17/1994 | US5312751 Hybridoma producing a monoclonal antibody specific for an antigen of the stratum corneum of human epidermis |
| 05/17/1994 | US5312629 Method for treating mucoviscidosis and chronic pain syndromes deriving from degenerative locomotor diseases |
| 05/11/1994 | WO1994010569A1 METHODS AND COMPOSITIONS FOR THE DETECTION OF SOLUBLE β-AMYLOID PEPTIDE |
| 05/11/1994 | WO1994009781A1 Use of bhap compounds in combination with other non-nucleoside reverse transcriptase inhibitors for the treatment of hiv infection |